Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2011-08-02
2011-08-02
Myers, Carla (Department: 1634)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S071100, C435S320100, C435S252300, C536S023500, C536S024300, C530S350000
Reexamination Certificate
active
07989182
ABSTRACT:
A method of identifying a subject predisposed to a disorder associated with ion channel dysfunction, comprising ascertaining whether at least one of the genes encoding ion channel subunits in said subject has undergone a mutation event such that a cDNA derived from said subject has the sequence set forth in one of SEQ ID NOS: 1-134.
REFERENCES:
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 4172124 (1979-10-01), Koprowski et al.
patent: 4474893 (1984-10-01), Reading
patent: 4971903 (1990-11-01), Hyman
patent: 5331573 (1994-07-01), Balaji et al.
patent: 5579250 (1996-11-01), Balaji et al.
patent: 6331614 (2001-12-01), Wong et al.
patent: 7078515 (2006-07-01), Wallace et al.
patent: 7282336 (2007-10-01), Wallace et al.
patent: 7709225 (2010-05-01), Wallace et al.
patent: 7723027 (2010-05-01), Petrou et al.
patent: 2003/0157525 (2003-08-01), Mintier et al.
patent: 2004/0096886 (2004-05-01), Rouleau et al.
patent: 2004/0110706 (2004-06-01), Wallace et al.
patent: 2004/0214195 (2004-10-01), Rouleau et al.
patent: 2004/0229257 (2004-11-01), Petrou et al.
patent: 2005/0074764 (2005-04-01), Mulley et al.
patent: 2006/0089306 (2006-04-01), Wallace et al.
patent: 2006/0252121 (2006-11-01), Wallace et al.
patent: 2009/0081724 (2009-03-01), Mulley et al.
patent: 2010/0088778 (2010-04-01), Mulley et al.
patent: 2010/0136623 (2010-06-01), Mulley et al.
patent: 2010/0203548 (2010-08-01), Petrou et al.
patent: 656247 (1996-06-01), None
patent: WO84/03564 (1984-09-01), None
patent: WO97/02048 (1997-01-01), None
patent: WO 01/38564 (2001-05-01), None
patent: WO01/88125 (2001-11-01), None
patent: WO01/98486 (2001-12-01), None
patent: WO 02/06521 (2002-01-01), None
patent: WO 02/50096 (2002-06-01), None
patent: WO03/008574 (2003-01-01), None
patent: WO 2004/085674 (2004-10-01), None
patent: WO 2005/014863 (2005-02-01), None
GenBank Accession No. AC0100127, NCBI Database, National Center for Biotechnology Information, National Library of Medicine, NIH (Bethesda, MD, USA), GI: 11597116, May 9, 2001.
GenBank Accession No. AC0100127, NCBI Database, National Center for Biotechnology Information, National Library of Medicine, NIH (Bethesda, MD, USA), GI: 11597116,Apr. 8, 2005.
Verma et al., Nature, 1997, vol. 389, pp. 239-242.
Orkin et al.“Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy”, NIH, 1995.
Thomas et al. Nature. 2003. 4: 346-358.
Abstracts of Decisions. Decision of a Delegate of the Commissioner of Patents corresponding to an Australian Patent Application No. 18465/01 issued Jan. 29, 2007.
Alekov et al., “A sodium channel mutation causing epilepsy in man exhibits subtle defects in fast inactivation and activation in vitro,”Journal of Physiology, vol. 529, No. 3, pp. 533-539 (2000).
Andermann, “Multifactorial Inheritance of Generalized and Focal Epilepsy,” Genetic Basis of the Epilepsies, pp. 355-374 (1982).
Annegers, “The Epidemiology of Epilepsy,” The Treatment of Epilepsy: Principles and Practice, Chpt. 11, pp. 165-172 (1996).
Baulac et al., “A Second Locus for Familial Generalized Epilepsy with Febrile Seizures Plus Maps to Chromosome 2q21-q33,” Am. J. Hum. Genet., vol. 65, pp. 1078-1085 (1999).
Bell and Lathrop, “Multiple loci for multiple sclerosis,” Nature Genetics, vol. 13, pp. 377-378 (Aug. 1996).
Berkovic et al., “Concepts of absence epilepsies: Discrete syndromes or biological continuum?” Neurology, vol. 37, No. 6, pp. 993-1000 (Jun. 1987).
Berkovic et al., “Familial Epilepsies in Israel: Clinical Syndromes and Modes of Inheritance,” Neurology, vol. 54, Suppl. 3, A356, No. P05.063 (Apr. 2000).
Berkovic et al., “The epilepsies: specific syndromes or a neurobiological continuum?” Epileptic Seizures and Syndromes, Chpt. 5, pp. 25-37 (1994).
Bertille Hille, “Ionic Channels of Exciteable Membranes,” 2ndEdition, pp. 423 and 434-444 (1992).
Bertrand et al., “Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy,” British J. of Pharmacology, vol. 124, pp. 1-10 (1998).
Bievert et al., “A Potassium Channel Mutation in Neonatal Human Epilepsy,” Science, vol. 279, pp. 403-406 (Jan. 16, 1998).
Bourgeois, “Chronic Management of Seizures in the Syndromes of Idopathic Generalized Epilepsy,” Epilepsia, 44 (Suppl. 2), pp. 27-32 (2003).
Breaker et al., “A DNA enzyme with Mg2+-dependent RNA phosphoesterase activity,” Chemistry and Biology, vol. 2, No. 10, pp. 655-660 (1995).
Cannon, “Sodium Channel Gating: No Margin for Error,” Neuron, vol. 34, pp. 853-858 (Jun. 13, 2002).
Cavazzuti et al., “Longitudinal Study of Epileptiform EEG Patterns in Normal Children,” Epilepsia, vol. 21, pp. 43-55 (1980).
Charlier et al., “A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family,” Nature Genetics, vol. 18, pp. 53-55 (Jan. 1998).
Chou et al., “The lack of association between febrile convulsions and polymorphisms in SCNIA,” Epilepsy Research, vol. 54, pp. 53-57 (2003).
Claes et al., “De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy,” American Journal of Human Genetics, vol. 68, pp. 1327-1332 (2001).
Cole et al., “Human monoclonal antibodies,” Molecular and Cellular Biochemistry, vol. 62, pp. 109-120 (1984).
Collins, “Positional cloning moves from perditional to traditional,” Nature Genetics, vol. 9, pp. 347-349 (Apr. 1995).
Commission on Classification and Terminology of the International League Against Epilepsy, “Proposal for Revised Classification of Epilepsies and Epileptic Syndromes,” Epilepsia, vol. 30, No. 4, pp. 389-399 (1989).
Communication pursuant to Rule 46(1) EPC corresponding to European Application No. 04718885.9-2402 PCT/AU2004000295 dated Jul. 14, 2006.
Cote et al., “Generation of human monoclonal antibodies reactive with cellular antigens,” Proceedings of the National Academy of Sciences of the USA, vol. 80, pp. 2026-2030 (1983).
Doose and Baier, “Genetic aspects of childhood epilepsy,” Cleveland Clinic Journal of Medicine, vol. 56, Suppl. Part 1, S101-5110.
Doose and Baier, “Genetic Factors in Epilepsies with Primarily Generalized Minor Seizures,” Neuropediatrics, vol. 18, Suppl. I, pp. 1-64 (Feb. 1987).
Dworakowska and Dolowy, “Ion channels-related diseases,” ACTA Biochimica Polonica, vol. 47, No. 3, pp. 685-703 (2000).
Escayg et al., “Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2,” Nature Genetics, vol. 24, pp. 343-345 (Apr. 2000).
Escayg et al., “A Novel SCN1A Mutatin Associated with Generalized Epilepsy with Febrile Seizures Plus- and Prevelance of Variants in Patients with Epilepsy,” Am. J. of Hum. Genet., vol. 68, pp. 866-873 (2001).
European Patent Office Search Report dated Apr. 10, 2007 for European Patent Application No. 07075566.52401.
Examiner's First Report for Australian Patent Application No. 2004200978 dated May 6, 2004.
European Patent Office Search Report corresponding to European Patent Application No. 07075566.5-2401 dated Oct. 4, 2007.
European Patent Office Search Report corresponding to European Patent Application No. 04718885.9-2402 PCT/AU2004000295 dated Jul. 14, 2006.
Finkelstein et al., “Use of denaturing gradient gel electrophoresis for detection of mutation and prospective diagnosis in late onset ornithine transcarbamylase deficiency,” Genomics, vol. 7, pp. 167-172 (1990).
Fong et al., “Childhood Absence Epilepsy with Tonic-Clonic Seizures and Electroencephalogram 3-4-Hz Spike and Multispike—Slow Wave Complexes: Linkage to Chromosome 8q24,” Am. J. Hum. Genet. vol. 63 pp. 1117-1129 (1998).
Fujiwara et al., “Mutations of sodium channel a subunit type 1 (SCNIA) in intractable childhood epi
Berkovic Samuel Frank
Dibbens Leanne Michelle
Harkin Louise Anne
Heron Sarah Elizabeth
Mulley John Charles
Bionomics Limited
Jenkins Wilson Taylor & Hunt, P.A.
Myers Carla
LandOfFree
Nucleic acid encoding SCN1A variant does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid encoding SCN1A variant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid encoding SCN1A variant will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2731963